prostate cancer

Chapters: 0:34 What is testosterone replacement therapy (TRT)? 2:29 What is the dosing? 2:50 Explain adding testosterone when you are on ADT? 4:43 What is a normal testosterone level and one for someone on ADT? 7:10 How does quality of life and testosterone level relate? 7:55 Does...

Great webinar! Our aim is to assess the effects of testosterone replacement therapy (TRT) on male health indicators in hypogonadal men, and the impact on sexual quality of life and prostate cancer risk. Testosterone prescriptions have nearly tripled in recent years; however, it is clear...

Great webinar! Nelson's house is where it's at! 3:20-18:38 * Safety of TTh in men with treated or low-grade in-situ prostate cancer is unknown * Will never have a study large enough to know true impact of T on prostate cancer development/progression

In the video, Dr. Marshalls, a medical oncologist with 30 years of experience in prostate cancer, discusses various blood tests used for prostate cancer screening. He explains the limitations of PSA (Prostate-Specific Antigen) tests, which can indicate issues with the prostate gland but are not...

https://ascopost.com/videos/2024-asco-annual-meeting/alicia-morgans-and-samuel-denmeade-on-prostate-cancer-results-from-the-transformer-trial/

Another great interview from Dr. Bernie! * debunk the long-standing myth that testosterone fuels prostate cancer In this episode, Dr. Geo interviews Dr. Helen Bernie from Indiana University about Testosterone Replacement Therapy (TRT) post-prostate cancer diagnosis and treatment. They...

As part of the 2024 Prostate Cancer Patient Conference, Dr. Eric Small reviews Androgen Deprivation Therapy, including choices of agents, side effects, considerations in timing, duration, intensity of therapy, and discusses interpretation of clinical trial results.

Join Dr. Geo as he delves into the genetics behind prostate cancer with Dr. Eric Klein, a renowned expert in the field. This episode covers the role of genetic predispositions, the science behind liquid biopsies, and their application in cancer detection, particularly prostate cancer. Dr. Klein...

Men have many challenges to deal with when battling prostate cancer, including managing the side effects of their treatment. One common issue men face after a radical prostatectomy is erectile dysfunction. As June is Men's Health Month, we are fortunate to have men's health expert Dr. Helen...

ABSTRACT Men with hypogonadism have reduced risk of prostate cancer mortality; whether testosterone treatment increases the risk of prostate safety events in men with hypogonadism remains controversial. Several studies including four larger randomized trials — the Testosterone Trials...

Lesson 20 https://auau.auanet.org/content/update-series-2024-audio-playlist?destination=node/38867/course-outline#group-tabs-node-course-default1

In this episode of the Dr. Geo Podcast, Dr. Geo sits down with Dr. Daniel Margolis, a professor of radiology and the director of prostate MRI at Weill Cornell Medicine, to discuss the importance of MRI in prostate cancer screening. They delve into the essentials of MRI technology, the expertise...

The EAU Guidelines Office will provide a state-of-the-art update on male hypogonadism and testosterone replacement therapy. This recording will be of great educational value for urologists as internationally-known experts will focus on the controversial and challenging areas of this rapidly...

Chapters Timeline: 4:48 Physical activity and exercise are important to make you feel better plus mental health booster 5:31 What comes to mind from the Genetics lecture? 9:24 How does liquid biopsies relate to early screening? 14:29 15-20 years ago total body CT scans not finding...

0:22 What is the difference between a "genetic" and a "genomic" test? 1:12 How important is genetic or genomic testing to the average prostate cancer patient? 3:31 Do 5% of people have a BRCA mutation? 3:42 Should all prostate cancer patients test to see if they have a BRCA mutation? 5:09...

"We've been doing a lot of work at Johns Hopkins using high-dose testosterone therapies to treat patients with metastatic prostate cancer," says Mark C. Markowski, MD, PhD. https://www.urologytimes.com/view/bipolar-androgen-therapy-in-prostate-cancer-current-evidence-and-next-steps In this...

Background and purpose To determine the rate and time of testosterone (T) recovery in patients (pts) with localised prostate cancer treated with radiotherapy plus 0-, 6-, 18- or 36-month of androgen deprivation therapy (ADT).Materials and methods In 1230 pts with prostate cancer randomised into...

https://pcri.org/2024-midyear-update

Dr. Michael Kipper, MD is one of the nation’s foremost experts in PET/CT imaging technology for the diagnosis of cancer and brain disorders. He is the author of several medical textbooks and numerous professional journal articles on imaging techniques for the evaluation of cancer and other...

10 Years of MRI-Targeted Biopsy: What We Have Learned, and What We Have Yet to Learn by Samir S. Taneja, MD, The James M. Neissa and Janet Riha Neissa Professor of Urologic Oncology, Professor of Urology, Radiology, and Biomedical Engineering, GU Program Leader, Perlmutter Cancer Center...

I was recently honored to be a guest speaker among the innovators, stakeholders, and pioneering minds in managing benign prostate hyperplasia at the annual assembly of the Society of Benign Prostate Disease, held in Dallas this February. Today, I am delighted to have one of the Society of...

Chapters: 2:07 What is the pathology process, and what does a Gleason score mean? 4:54 How should a patient broach questions about treatment with their physician? 9:27 Should patients seek out their pathology report? Can they trust it? 11:22 Can Gleason 6 ever metastasize? 13:04 How likely...

In today's episode with Stacey Loeb, we're delving into the critical topic of prostate cancer — sifting truth from myths and exploring both prevention and treatment options. Dr. Loeb, a professor of urology with a personal investment in the field, joins us to debunk common misinformation about...

Focal Therapy in Prostate Cancer: Is it Ready for Prime Time? By Dr. Sandra Kim, Uro-Oncology Fellow, Department of Urologic Sciences, University of British Columbia

1:02 What is PSA used for, and how is it measured? 2:36 Is PSA the only way to screen for prostate cancer? 4:53 Is there any reason to get a Digital Rectal Exam? 5:47 What is PSA density, and how large is the average prostate? 7:13 How accessible and affordable are MRIs, usually? 7:38 How...

In this comprehensive interview, host Dr. Geo chats with guest expert Dr. Samir Taneja from NYU Langone Medical Center. They unpack the shift in prostate cancer diagnostics from traditional methodologies to more effective approaches using MRI and ultrasound technology. They also touch on the...

Weighing the possible side effects of prostate cancer treatments while considering various treatment options can be a daunting challenge for men and their loved ones. We are excited to partner with BioProtect for this episode, with our distinguished guest, Dr. Jonathan Tward, a Radiation...

1:03 At what stage of prostate cancer would TULSA-PRO be most useful? 3:15 At what Gleason score is TULSA-PRO most often recommended? 4:15 How long does a usual TULSA-PRO procedure usually take to complete? 4:58 What are the most common TULSA-PRO side effects? 5:45 Is urethral scar tissue a...

On October 17, Dr. Abraham Morgentaler, son of writer Chava Rosenfarb, delivered a lecture on "Lodz, testosterone and human dignity" as part of the International Scientific Conference "CHAVA ROSENFARB AND JEWISH WRITERS OF THE 20th CENTURY." In this lecture, Dr. Morgentaler described his...

Chapters 1:08 What are the new PARP Inhibitors, Talzenna and Akegga? 2:18 How effective has PSMA been at helping patients delay chemotherapy? 5:08 What was the state of active surveillance in 2023? 5:56 What is Prostox and can it apply to spot radiation? 7:49 What was the state of Pluvicto...